2021 Research Funding

Donations to The Leukemia & Lymphoma Society of Canada contribute to blood cancer research funding. There are many scientists in hospitals and cancer centres across the country who are looking for financial support in order to start or continue their projects in blood cancer research.

The Leukemia & Lymphoma Society of Canada has a long-standing history of funding cancer research that began in 1955 when five Toronto women concerned about the lack of leukemia research started fundraising. Today, we are the largest voluntary health agency in Canada that is dedicated not only to leukemia but to all types of blood cancers.

Donate Today      

 

 

2021 Grants

Specialized Center of Research (SCOR) grant program

The Leukemia & Lymphoma Society of Canada is proud to provide funding to support Dr. Tak Mak’s SCOR grant awarded by The Leukemia & Lymphoma Society (LLS). LLS’s Specialized Center of Research (SCOR) grant program is intended to bring together established investigators from one or several institutions to develop a focused research program, foster new interactions and cooperation, and enhance interdisci...

Translational Research Program

The Leukemia & Lymphoma Society of Canada is proud to partner with the Leukemia & Lymphoma Society (US) to provide funding for Translational Research Program grants awarded to Canadian researchers.

The Translational Research Program (TRP) puts you on the bench-to-bedside fast track when it comes to finding better treatment and cures for blood cancers. The LLSC and LLS funds new and innovat...

2021 LLSC-LLS Career Development Program – Special Fellow Grant

2021 LLSC-LLS Career Development Program – Special Fellow Grant

The Leukemia & Lymphoma Society of Canada, in partnership with the Leukemia and Lymphoma Society (US), is pleased to announce the recipient of a 2021 CDP Special Fellow Award.

The Leukemia & Lymphoma Society (US) offers career development awards to postdoctoral fellows and instructors, as well as early-career independent investigators, engaging in basic, translational, or clinical research to h...

Exciting new research partnership

The Leukemia & Lymphoma Society of Canada, in partnership with the Canadian Cancer Society (CCS), is pleased to announce the recipient of a 2021 CCS Spark Grant. The intent of the Novel Technology Application in Cancer Prevention and Early Detection program is to “spark” and accelerate new activity in the development and/or application of truly novel approaches to cancer prevention and early detection. ...

2020 Clinician Scientist Fellow Award (in partnership with CIHR)

The intent of the Clinician Scientist Fellow Award is to encourage early-stage specialist clinicians to pursue a career in blood cancer research. This opportunity is designed to foster the acquisition of skills and independence to conduct research in blood cancers at the laboratory, clinical or combined levels. The Leukemia & Lymphoma Society of Canada, in partnership with the Canadian Institutes of Health Res...

Operating grant recipients

Our Operating Grants offer funding (up to $100,000/year) for two-years for basic research that contributes to the advancement of science aimed at preventing, detecting and treating blood cancers. These grants recognize scientists whose work will contribute to the tremendous momentum in blood cancer research and yield groundbreaking results in treating patients and extending lives.